Characterization of subtilase protease in Cryptosporidium parvum and C. hominis

Xiaochuan Feng1, Donna E Akiyoshi, Giovanni Widmer

  • 1Division of Infectious Diseases, Tufts Cummings School of Veterinary Medicine, North Grafton, Massachusetts 01536, USA.

Insights

Cryptosporidium subtilase (SUB1) is crucial for parasite development. Inhibiting this serine protease significantly blocks Cryptosporidium infection, highlighting its potential as a drug target.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Biochemistry

Background:

  • Cryptosporidium spp. are apicomplexan enteropathogens.
  • Proteases are vital for apicomplexan host cell invasion and survival.
  • Subtilases are a conserved family of serine proteases.

Purpose of the Study:

  • To characterize the Cryptosporidium parvum subtilase gene (CpSUB1) and its homolog in Cryptosporidium hominis (ChSUB1).
  • To investigate the role of CpSUB1 in parasite development and its potential as a drug target.

Main Methods:

  • Homologous polymerase chain reaction (PCR) was used to identify ChSUB1.
  • Nucleotide sequence alignment and analysis of CpSUB1 and ChSUB1.
  • Transcriptional analysis during merozoite development in cell culture.
  • Testing the effect of serine protease inhibitors on Cryptosporidium parvum infection.

Main Results:

  • CpSUB1 and ChSUB1 genes show high nucleotide identity (98%).
  • CpSUB1's catalytic domain is conserved among Apicomplexa and bacterial subtilisins.
  • CpSUB1 transcription is upregulated during merozoite development.
  • Serine protease inhibitors significantly inhibit Cryptosporidium parvum infection in cell culture.

Conclusions:

  • The subtilase gene CpSUB1 is conserved between Cryptosporidium parvum and Cryptosporidium hominis.
  • CpSUB1 is essential for the intracellular development of Cryptosporidium parasites.
  • CpSUB1 represents a promising drug target for treating Cryptosporidium infections.